Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Taylor AM, Waldstreicher J. McConnell JD, et al. Among authors: wang dz. N Engl J Med. 1998 Feb 26;338(9):557-63. doi: 10.1056/NEJM199802263380901. N Engl J Med. 1998. PMID: 9475762 Free article. Clinical Trial.
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.
Roehrborn CG, Boyle P, Bergner D, Gray T, Gittelman M, Shown T, Melman A, Bracken RB, deVere White R, Taylor A, Wang D, Waldstreicher J. Roehrborn CG, et al. Urology. 1999 Oct;54(4):662-9. doi: 10.1016/s0090-4295(99)00232-0. Urology. 1999. PMID: 10510925 Clinical Trial.
Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
Bruskewitz R, Girman CJ, Fowler J, Rigby OF, Sullivan M, Bracken RB, Fusilier HA, Kozlowski D, Kantor SD, Johnson EL, Wang DZ, Waldstreicher J. Bruskewitz R, et al. Among authors: wang dz. Urology. 1999 Oct;54(4):670-8. doi: 10.1016/s0090-4295(99)00209-5. Urology. 1999. PMID: 10510926 Clinical Trial.
Corrigendum to "Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis" [Vascular Pharmacology 155 (2024) 107368].
Singh B, Cui K, Eisa-Beygi S, Zhu B, Cowan DB, Shi J, Bashur CA, Wang DZ, Liu Z, Bischoff J, Chen H. Singh B, et al. Among authors: wang dz. Vascul Pharmacol. 2024 Apr 23:107373. doi: 10.1016/j.vph.2024.107373. Online ahead of print. Vascul Pharmacol. 2024. PMID: 38658307 No abstract available.
Polarizability matters in enantio-selection.
Chen F, Chen Y, Chang XY, He D, Yang Q, Wang DZ, Xu C, Yu P, Xing X. Chen F, et al. Among authors: wang dz. Nat Commun. 2024 Apr 22;15(1):3394. doi: 10.1038/s41467-024-47813-4. Nat Commun. 2024. PMID: 38649371 Free PMC article.
583 results